Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Actions Against Food Firms May Predict Aggressive Follow-Through

This article was originally published in The Tan Sheet

Executive Summary

FDA's use of more serious tools against repeat offender food manufacturers suggests similar aggressive actions could await food and dietary supplement firms testing the agency's patience

You may also be interested in...



Senate Exempts Supplements From Redundant Regs, Suppliers Left Hanging

The Senate's food safety reform bill relieves the dietary supplement industry's biggest concern about the legislation by excluding supplement firms from duplicative manufacturing regulations

Salmonella Problem Stirs Food Safety Bills, Hearing From Energy & Commerce

At an upcoming hearing, House Energy and Commerce Committee leaders will question executives from labs that tested ingredients at the peanut processing facility linked to widespread recalls due to salmonella contamination

Hi-Tech Prosecution Offers FDA Model For Pursuing Bad Actors – Lawyer

The successful prosecution of Hi-Tech Pharmaceuticals for counterfeiting generic Rx drugs should encourage FDA to pursue criminal charges against other companies selling adulterated products, according to food and drug attorney Marc Ullman

Topics

UsernamePublicRestriction

Register

PS103679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel